InvestorsHub Logo
Followers 30
Posts 4082
Boards Moderated 0
Alias Born 07/25/2007

Re: Inoviorulez post# 760

Sunday, 01/12/2020 12:31:31 PM

Sunday, January 12, 2020 12:31:31 PM

Post# of 977

Day Traders getting out likely. It doesn't matter compliance news is approaching Wednesday. After that I expect take off, also partnership for CD47 products or STING lined up.



Exactly. If TRIL closes over $1 on wednesday, the threat of delisting is gone. I have no problem with day traders, but I hate when they clutter up the board with their repetitive nonsense. A partnership with some really nice up front cash would be great but I sure hope management doesn't sell TRIL short.

Presentation slides mentioned STING out licensing expected 1st half 2020. TRIL going higher.




I too expect TRIL to go higher, especially if FTSV trial data with the anti-CD47 drug combo trial continues to show positive data before TRIL's TTI-621 trial reports new data. FTSV doesn't have a cash shortage but TRIL does. Therefore, if TRIL keeps rising I expect some sort of stock issuance to raise some much needed cash. Being in a stronger financial position will enhance their bargaining position if some company decides they want to partner with TRIL.